- Home
- POET vs AVR Comparison
POET vs AVR Comparison
Compare POET & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- AVR
- Stock Information
- Founded
- POET 1972
- AVR 1999
- Country
- POET Canada
- AVR Australia
- Employees
- POET N/A
- AVR N/A
- Industry
- POET Semiconductors
- AVR
- Sector
- POET Technology
- AVR
- Exchange
- POET Nasdaq
- AVR NYSE
- Market Cap
- POET 275.1M
- AVR 241.5M
- IPO Year
- POET N/A
- AVR 2024
- Fundamental
- Price
- POET $3.78
- AVR $2.88
- Analyst Decision
- POET Strong Buy
- AVR Strong Buy
- Analyst Count
- POET 2
- AVR 4
- Target Price
- POET $6.25
- AVR $16.50
- AVG Volume (30 Days)
- POET 936.8K
- AVR 408.9K
- Earning Date
- POET 05-14-2025
- AVR 05-16-2025
- Dividend Yield
- POET N/A
- AVR N/A
- EPS Growth
- POET N/A
- AVR N/A
- EPS
- POET N/A
- AVR N/A
- Revenue
- POET $41,427.00
- AVR $2,703,000.00
- Revenue This Year
- POET $9,379.33
- AVR $29.52
- Revenue Next Year
- POET $684.42
- AVR $204.83
- P/E Ratio
- POET N/A
- AVR N/A
- Revenue Growth
- POET N/A
- AVR N/A
- 52 Week Low
- POET $1.00
- AVR $2.34
- 52 Week High
- POET $7.79
- AVR $8.79
- Technical
- Relative Strength Index (RSI)
- POET 48.49
- AVR N/A
- Support Level
- POET $3.65
- AVR N/A
- Resistance Level
- POET $4.00
- AVR N/A
- Average True Range (ATR)
- POET 0.36
- AVR 0.00
- MACD
- POET 0.03
- AVR 0.00
- Stochastic Oscillator
- POET 65.71
- AVR 0.00
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.